On October 27, 2023, the Federal Trade Commission (“FTC”) approved an amendment (“Amended Rule”) to the Standards for Safeguarding Customer Information (the “Safeguards Rule”) that will require non-banking financial institutions…
On October 16, 2023, the SEC’s Division of Examinations (“EXAMS”) issued its 2024 Examination Priorities (the “2024 Priorities”). The 2024 Priorities reflect the Commission’s continued scrutiny of information security and…
On August 17, 2023, we published an article on Board Responsibility for AI Risk Oversight with Directors & Boards, covering: The promises and risks of AI adoption The rapidly evolving…
On July 26, 2023, the U.S. Securities and Exchange Commission (“SEC”) issued proposed rules (the “Proposed Rules”) that would require broker-dealers and investment advisers (collectively, “firms”) to evaluate their use…
On July 26, 2023, the SEC adopted long-anticipated final rules on cybersecurity risk management, strategy, governance and incident disclosure for issuers (“Final Rules”). We summarized the key obligations under the…
On July 26, 2023, the SEC adopted the long-anticipated final rules on cybersecurity risk management, strategy, governance, and incident disclosure for issuers. The new rules are part of the SEC’s larger efforts focused…
On March 15, 2023, the U.S. Securities and Exchange Commission (the “SEC”) released a suite of proposed new rules (the “Proposed Rules”) that include: Proposed new cybersecurity rules for broker-dealers,…
We have written several times about the need for companies to reduce the amount of data that they collect and to get rid of old data. Data minimization lowers the…
On March 2, 2023, the White House Office of the National Cyber Director (“ONCD”) released the Biden Administration’s (the “Administration”) long-awaited National Cybersecurity Strategy (the “Strategy”), the first since the…
On February 27, 2023, the FTC released guidance entitled “Keep Your AI Claims in Check” (“AI Claims Blog Post”), reminding companies that false or unsubstantiated claims about a product’s efficacy…